Serotonin-norepinephrine reuptake inhibitors (SNRIs) and Sigma receptor ligands combinations
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 3, 2018
Issued Date -
N/A
app pub date -
Dec 16, 2014
filing date -
Dec 17, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention refers to a synergistic combination comprising a Sigma ligand of general formula (I), and a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament, particularly for the prophylaxis and/or treatment of pain.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully